Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
is anyone here as excited about this company as I? seems like only 4 of us know about this.
I'm here too LOL
$CBDHF
lol looks like only THREE of us here going to reap the 10x rewards here. its a ghost town. doesnt matter. the 3 of us are good!
bigtime move coming to 1.00 plus me thinks here. great company too. CBD.U
i feel like amazing news might be coming? CBDHF
If this is clearly going back over $1! It's such a good company
CBDHF...2015s clearing here...Break/Hold the 50ma would be very Bullish here...imo...we shall see...:party:
[9:47 AM]
georgie18 — 11/05/2021
CBDHF...16...Taking a starter on the Bullish Harami Cross Reversal Pattern to the Upside...off the bottom support...
Will add accordingly up or down...:party:
NICE HEADS UP FINGERS...
CBDHF...16...Taking a starter on the Bullish Harami Cross Reversal Pattern to the Upside...off the bottom support...
Will add accordingly up or down...
Chart...https://schrts.co/jaqVIeMG ...
All these employees options are at .24! If this isnt a bargain here at .16, i dont know what is. See you guys above 1.00 IMO. CBDHF
I believe you are right.
$SCNA
wabadon
im VERY surprised noones really posting here. This is about to be the best stock on the OTC soon i think. CBDHF
this new news is great. this increase in PP is a huge confidence builder for this company long term!!! CBD
I looked at all the filings and news and share structure oh my God this is so undervalued
Good on ya. I’m tied up in other plays. So holding what I have
bought more at .24
Would be nice. CBDHF
2.00 most likely. with that kind of investment and NO DISCOUNT TO MARKET, they must believe this is going into the dollars IMO. CBD
To be used for working capital and MARKETING. This could easily get back to 1,2,3? dollars. CBDHF
thats INCREDIBLE NEWS> NO DISCOUNT TO MARKET and MAJOR INVESTMENT. WARRANTS can be 100% HIGHER than current market!!!!!!!!! Best we could hope for guys. CBD
HempFusion Announces USD$2,000,000 Strategic Private Placement
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
FOR DISSEMINATION IN THE UNITED STATES
DENVER--(BUSINESS WIRE)--August 27, 2021--HempFusion Wellness Inc. (TSX:CBD.U)
(OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and
wellness Company offering premium probiotic supplements and products containing CBD, is
pleased to announce a non-brokered private placement of 8,000,000 units of the Company (the
“Units”) at a price of USD$0.25 per Unit for gross proceeds of USD$2,000,000 (the “Private
Placement”). Each Unit is comprised of one common share in the capital of the Company (a
“Common Share”) and one-full Common Share purchase warrant (a “Warrant”). Each whole
Warrant will entitle the holder to acquire one additional Common Share at a price of USD$0.50
per Common Share for a period of four years from the closing date of the Private Placement,
expected on or about September 12, 2021. Closing of the Private Placement is subject to a
number of conditions, including receipt of all necessary corporate and regulatory approvals,
including approval of the Toronto Stock Exchange.
The Company plans to allocate the gross proceeds of the Private Placement to general working
capital and marketing initiatives.
All securities issued under the Private Placement will be subject to a statutory hold period of four
months plus a day from the date of issuance in accordance with applicable securities legislation.
Today is better, do the math! Clearly significantly UNDERVALUED.
HempFusion Provides Corporate Update, Revenue Guidance
DENVER, Colo., August 25, 2021 - HempFusion Wellness Inc. (TSX: CBD.U) (US: CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to provide a corporate update and proforma revenue guidance including its two recently completed acquisitions, APCNA Holdings LLC (“Apothecanna”) and Sagely Enterprises Inc. (“Sagely Naturals”), (together with the “Acquisitions”) for fiscal 2021 and 2022.
Based on a fiscal 2020 pro forma revenue basis, HempFusion (combined with the fiscal 2020 revenues of Apothecanna and Sagely Naturals) would have generated approximately USD$11.8 million in revenue. With the completion of the Acquisitions and inclusion of the pre-closing fiscal 2021 revenues of Apothecanna and Sagely Naturals, HempFusion expects to generate revenues of between USD$12.5 million and $13.5 million in fiscal 2021 and USD$20 million to $25 million in fiscal 2022 due in large part to the Company’s expansion plans over the next 18 months and beyond. The Company maintains a clean balance sheet with approximately USD$11.4 million cash as of the end of the Company’s second fiscal quarter.
HempFusion’s combined footprint includes the following:
Distribution to over 15,000 retail locations including Publix, Walgreens, CVS, Rite Aid, Albertsons, Sprouts, Nordstrom, Whole Foods, and Kroger, with several more significant retailers expected to launch in the coming weeks.
Due to the broad consumer reach of the family of companies owned by HempFusion, the Company is able to appeal to roughly 80% of the current population of CBD purchasers including women, Baby Boomers and, the “Gellennial” crossover (Gen X and Millennial).
Six sales channels including its newly launched private label division!
Revenue growth is anticipated to be driven heavily by our robust investment into our DTC (Direct To Consumer) e-commerce platform that has already shown early-stage success.
Global footprint across multiple countries including, but not limited to, USA, Canada, Ireland, United Kingdom, Mexico, South Korea, United Arab Emirates, and China with several more now in the final execution phase
The #1 brand in CBD topicals, with 23% market share in the Drug channel [Drug (IRI-SPINScan 52 week ending 7-11-2021)] and 13.8-per-cent market share in the multiple outlet channels [MULO (IRI-SPINScan 52 week ending 7-11-2021)] and the #1 brand in a top-five largest FDM channel retailer [NielsenIQ product share report from a largest retail grocery chain in the Southeastern US (Nielsen Consumer, LLC., pull week ending 5/22/21)].
A diverse management team with cross-divisional synergies and incredible employees
Substantial investment into regulatory compliance creating a strong base for future FDA regulatory guidelines
Exclusivity of the entire supply chain from soil to oil
Strategic production relationships that enable the Company to meet demand with little to no anticipated disruption in service as operations scale
With the recent closing of the Acquisitions, HempFusion now has the significant distribution of market-leading products into thousands of retailers globally, as well as the ability to roll out highly compliant, organic-certified ingestible through multiple e-commerce and retail platforms. Upon the anticipated approval of ingestible from major retailers, the Company expects to rapidly fill its newly expanded pipeline. Additionally, HempFusion plans to leverage the investment it has made in international distribution to bring a more robust offering to Europe and Asia, including expanding its already strong partnership with gigantic marketplace Alibaba Inc T-Mall.
“I am pleased to present revenue guidance for 2021 and 2022 to our investor community,” commented Dr. Jason Mitchell, the Company’s Chief Executive Officer. “With the Acquisitions closed, not only do we reach over 15,000 retail locations and sell products in eight countries, but we’re also targeting up to $30 million in revenue for 2022. Combining this with our regulatory preparedness for ingestible CBD, we believe that we are poised to be the outstanding leader in the CBD industry. With a current market capitalization under $40 million, we hope this provides investors with a strong sense of confidence in our Company and sets us apart from our competitors,” continued Mr. Mitchell.
ABOUT HEMP FUSION
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com
or www.probulin.com
.
Follow HempFusion on Twitter
, Facebook
and Instagram
and Probulin on Twitter
, Facebook
and Instagram
.
CONTACT INFORMATION
Jason Mitchell, N.D.
Chief Executive Officer and Director
Email: ir@hempfusion.com
Phone: 416-803-5638
it sure was! this will be back to 1.80 in a jiffy! CBD
Many canadian stocks seem to do that. Probably Algos cycling through pre-determined moves
Hi guys, some reflections; Despite reaching strategic goals and a strong revenue stream (relative to its a fairly new company) - the share price is continuing to be a sad story. I was hopeful at the Q2 report, but no; the market is VERY cold for now.
Reasons are a combination of factors, yet I think one big issue, is the lack of contact with retail investors/traders. Personally, I have written several times, to IR, support, and info-email, none of them replied. Is it anyone else that also shares this bad experience?
No way (as I know) to get to the CEO by email. No investors-group page on Fb (elsewhere?) No faces to connect to, except the CEO. SAD. With so many good qualities, ticking most boxes - the IR bit is totally neglected (my experience).
Maybe hybris and "don`t care/count" retail investors... well, they certainly don`t build brand ambassadors, that`s for sure. Grassroots power is not to be underestimated - products may be top-notch, Investor Relations is non-existent, a huge mistake in my view, all IMO
Obvious from the tremendous volume & RED finish.
Sooooooo undervalued LOL
Soooooo many believers.
Soooooo many other options- like stocks that actually GO UP.
Breaking even is better than this POS.
LMAO
O11
man! this is the most undervalued company on OTC right now IMO> amazing SS and any group run can take this to the 2.00 range. CBDHF
whats all this unusual ask lot movements? cant they fkn make up their minds.
Interesting. SP has taken a beating, but they did do a lot of aquisitions. Migh be time to start turning up based on very nice revenue increases.
"Marketrealist" HempFusion Offers Diversity in CBD Market
https://marketrealist.com/p/is-hempfusion-stock-a-good-buy/
Some reflections on the stock, trying to keep the board alive
Giving the double up in annual revenue, we are on the right way.
However, I would like them to be a bit tighter with expenses.
To sum up; progress is on, yet one always hopes for more... the progress was not enough to excite the market - that is an issue the company has to deal with ASAP.
I love the strategy of the business, yet they must step up when it comes to PR and Marketing, Investor Relations overall.
Alexulf, my apologies for not responding earlier. Additionally, I have very little time with my job, to pay too much attention to the market. So I am merely a dabbling investor. I hope for a day when I am not putting in 60/70 hours per week at work and can devote more time to being a better investor/trader. So I must pass at the opportunity to help moderate this board.
I have enjoyed your very informative posts and agree with your sentiments about HempFusion Wellness. I've yet to invest in this company but will keep a closer eye on the progress and get more educated about the organization and it's leadership.
Until then, keep up the great work.
Best regards.
HempFusion CBD Most Undervalued Stock On The Market Today? CEO Interview -
Second Quarter Earnings, Conference Call August 16, 2021
https://uk.finance.yahoo.com/news/hempfusion-wellness-inc-report-second-110500558.html
My prediction is we will see some "big money" real soon - before or after the quarterly report?
We must wait and see, all IMO, do your own research on the company.
Giving the fact in fall of the share price being so bad, I would not be surprised to see an equally strong bounce up - no other CBD company (to my knowledge) has a better position in the growing CBD market.
A double up now is still a long way to go at the previous high - with 3 revenue streams, the numbers will be strong and the market position even stronger for years to come.
Another 3 revenue streams are on the way to take place, see investor presentation; https://www.hempfusion.com/corporate-information/ (see download presentation)
HEMPFUSION WELLNESS INC REVIEWS -
https://www.trustpilot.com/review/hempfusion.com
https://americanmarijuana.org/hempfusion-cbd-review/
and; https://cbdclinicals.com/hempfusion-review/
International CBD Market Is The Key Solution For Hemp Fusion Wellness Inc.
Being present (number one brand in present, sales, and the number of products)in all major retail brands across the USA is a fact.
With Coffers Packed with Millions, HempFusion is Rising to the Top
Baystreet - Fri Feb 19, 6:21AM CST
https://www.barchart.com/story/news/1169089/with-coffers-packed-with-millions-hempfusion-is-rising-to-the-top
Within 4,5 months I count on the stock will hoover around + - 1 dollar.
Tomorrow IS THE DAY, Quarter 2 Report
Around the 15th of July, the stock stopped the fall.
The chart past 4 weeks; https://www.barchart.com/stocks/quotes/CBDHF/overview
The sell-off has been gigantic, IMO it`s very undervalued today. Giving the revenue numbers and promised strong report overall... I want a jump to no less than 0,33 - 0,34, the first resistant point.
Let`s see how the market reacts if the big money makes a move on the stock... then it could quickly double up! - time will tell
Have a good one guys!
Good morning guys, I will try to slow down... I just could not help it! However, who knows? Maybe main doomsday shouters are right? 90% stock market crash and the end of the world as we know it.
Then again, the growing fear leading to panic is not a sober way to analyze the market and the world in general. One must always ask; what is their agenda?
Contradictive messages, smoke, and mirrors. Personally, I try to stick to the facts;
when it applies to Hemp Fusion CBD, it looks to me they tick all the boxes - insider shareholding by management and directors as very important, strong finances and no debt, triple (3X) revenues now from acquisitions.
Quarterly next week will show how the market reacts.
Have good weekend traders and investors!
GoldRush, nice to meet you, contact admin and he set you up
Louis Navellier's Market 360 Brought to you by INVESTORPLACE
The Next Few Years Will Be the Best in Stock Market History (Here's How to Prepare)
Louis Navellier sees a tech/consumer goods megatrend on the rise that's going to shake the foundation of society... upending how we work, shop, communicate, and travel.
Full details, here.
Why the Stock Market is Going to Continue Climbing Higher
Louis Navellier
Louis Navellier
As you may know, I do not like August since it is a seasonally weak month for the stock market. What tends to happen is that lots of folks, especially traders in Europe and many on Wall Street, go on extended vacations, so “air pockets” can materialize.
I also anticipate both sales and earnings momentum will be decelerating in the upcoming months.
As an example, my average Breakthrough Stock’s sales and earnings are forecasted to slow to an annual pace of 83.2% and 377%, respectively. Essentially, this means that my Breakthrough Stocks are decelerating from 200 mph to about 178 mph! So, while they might be slowing down a tiny bit, they’re still
fundamentally superior
in my book.
Now, you may have recently caught wind of the “Chicken Littles” that the media likes to glorify. They’ve been busy issuing warnings that the U.S. economic growth has “peaked,” and the Covid-19 Delta variant will resume shutting economies around the world.
Although fear is good for media ratings, I would like to thoroughly explain why we are only in the fourth inning of a robust economic recovery and why the stock market is going to continue to meander higher.
Let’s start with second-quarter GDP, which has apparently barely accelerated over first-quarter GDP growth. Specifically, the preliminary estimate for second-quarter GDP from the Commerce Department’s U.S. Bureau of Economic Analysis came in at an annual rate of only 6.5%, which was substantially below economists’ consensus estimate of 8.4%.
The good news is that personal consumption recently rose at an 11.8% annual pace, which was significantly higher than economists’ consensus expectation. There are going to be multiple revisions to the second-quarter GDP estimate, but there is no doubt that the weaker-than-expected preliminary GDP report will provide the Federal Reserve more time to sustain its accommodative policy of low-interest rates and aggressive quantitative easing.
In the meantime, due to supply chain glitches, there is a strong order backlog, so I expect that third-quarter GDP will likely sustain at least 6% annual GDP growth.
Second, Modern Monetary Theory (MMT) — which, in part, asserts that its only limit to money creation is inflation — remains alive and well in Europe after the European Central Bank (ECB) boosted its quantitative easing and declared that it would not change interest rates until inflation reached a 2% annual rate.
This ECB action weakened the euro and caused foreign capital to pour into the U.S. seeking positive yields, versus the negative yields that are all too common in Europe.
The truth of the matter is that the U.S. is also embracing MMT and we are also on the path to negative interest rates, but first, we have to break a few key thresholds, like the 10-year Treasury bond falling and staying below the 1.2% level in the upcoming months. Currently, the 10-year Treasury bond is just below that at 1.19%.
Get access to all of my research at the lowest price we'll ever offer
For a limited time, I'm opening up access to my Platinum Growth Club for an incredibly low rate. But you have to act soon; the window is closing. Access my new incredible offer by
clicking here
.
Now, in my Breakthrough Stocks Monthly Issue, which comes out tomorrow (and is available to all
Platinum Growth Club
subscribers), I lay out three other key factors why I want you to invest with confidence and not worry about seasonal shenanigans or naysayers in the media.
The bottom line is that whatever deceleration the financial media is talking about for the S&P 500 is not really relevant for my
fundamentally superior stocks
.
For example, in the past three months, my average Breakthrough Stock has had its consensus earnings estimate revised 23.8% higher, which bodes well for more earnings surprises in the upcoming months. Meanwhile, 15 of my Breakthrough Stocks surged 7% to 20% in the past month and there are still more quarterly earnings announcements to be released in early August.
Buying the Crème de la Crème
Due to the current “Goldilocks” environment from low Treasury bond yields and strong earnings, the remainder of the year remains very positive. So, any pullbacks in the upcoming weeks will likely be great buying opportunities.
And I’m pleased to say that my
Platinum Growth Club
subscribers are perfectly positioned to benefit from these trends and much more.
You see, I have more than 100 stocks across all of my services
(plus 45 LEAPS call options or Long-term Equity Anticipation Securities in my Power Options trading service), and each and every one boasts strong earnings and sales growth.
Of course, you don’t have to invest in all 100+ stocks. If you’d rather start small, I’ve got you covered there, too. My
Platinum Growth Club
service comes with my exclusive Model Portfolio.
I handpick all of my Model Portfolio recommendations from my different stock services – Growth Investor, Breakthrough Stocks and Accelerated Profits – so you can rest assured that you’re always invested in the
crème de la crème
.
In addition to
access to my stocks and options recommendations
, you can read every single Weekly Update, Monthly Issue, Market Alert and Trade Alert, as well as exclusive podcasts and Live Chat events. Plus, you’ll receive a
Platinum Growth Club
Monthly Issue at the beginning of each month. In my latest
Platinum Growth Club
Monthly Issue, released on Monday, I recommended seven brand-new buys that boast
superior fundamentals
and are well-positioned to climb higher in the months ahead. And in last Friday’s Growth Investor Monthly Issue for August, I unveiled three defensive, high-growth stocks that I anticipate will be incredibly resilient in the upcoming weeks. These issues are available to you as soon as you sign u
p.
The bottom line: If you want to make sure your portfolio is “locked and loaded” with
fundamentally superior stocks
that will do well in the volatile month of August and the longer term, then I encourage you to sign up for
Platinum Growth Club
today.
For full details, click here
.
Sincerely,
Signed: Louis Navellier
This Is WHY CBD Wave Keep GROWING!
The Effects of Cannabinoids on Immune Function System. The pandemic is NOT OVER - and no one knows when it will be (if ever ).
HEALTH/WELLNESS is the future growth sector, that is a safe investment.
The Virus Is MUTATING - CBD can be one important part to protect yourself.
Update to explain the latest M&A deals and business model
What's the salary and benefit package like?
I need a moderator and/or assistance moderator, you up to it?
Reply here on the board, thanks.
Quarter 1 Report, Q 2 Coming Up Soon.
HempFusion Reports Q1, 2021 Financial Results
T.CBD.U | May 17, 2021
HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), an industry leader in full-spectrum cannabidiol (CBD) hemp extract wellness products and probiotics, today reported financial results for the first quarter ended March 31, 2021. All dollars are stated in US Dollars.
Q1-2021 Financial Highlights
Consolidated revenue increased 7.6% to $983,496 from $913,646 in Q4-2020
DTC sales increased 59.3% to $244,255 from $153,305 in Q4-2020
International sales increased to $75,994 from nil in Q4-2020
Gross profit of $280,205 or 28.5% of net revenue
Operating expenses were $6,306,703, an increase of 42.9% from $4,414,792 in Q1-2020, primarily attributed to IPO related expenses as well as marketing and digital related expenses
Strong cash position ending the quarter at $17,074,030
Q1-2021 Business Highlights
Completed a $17 million initial public offering (IPO) and commenced trading on the Toronto Stock Exchange (the “TSX”), becoming the first U.S.-based CBD and wellness products company to list directly on the TSX (senior board).
Became the No. 2 most recognized CBD brand in America according to Brightfield Group
As of the end of January 2021, NielsenIQ data rank HempFusion as the No. 1 in product sales and units sold in one of the largest food/drug/mass (“FDM”) retailers
E-Commerce success has shown a 62% increase in online traffic with a significant increase in conversion including a shift from 16.8% online sales in Q4-2020 as a percent of net revenue to 24.8% in Q1-2021
The Company launched the Probulin store on Amazon and early 2021 traction is encouraging. Consolidated net revenue for the three months ended March 31, 2021 increased 7.6% quarter-over-quarter to $983,496 versus $913,646 in Q4-2020. Direct to consumer (“DTC”) e-commerce net revenue increased 59.3% reflecting increased marketing efforts, a targeted DTC team and targeted digital promotions.
Not only did sales increase for both Probulin and HempFusion but the traffic has increased by 62% in Q1 2021 versus Q4 2020 with a conversion rate increase for Probulin of 2.1% to 3.2% and a current conversion rate for HempFusion of 3.4%. E-commerce accounted for 24.8% of net revenue in the first quarter of 2021 versus 16.8% for Q4, 2020. HempFusion's Probulin has seen 10% or greater month-over-month growth since launching on Amazon .
Officially launched Probulin on the world's largest e-commerce platform, Alibaba's Tmall Global, with HempFusion CBD following in a subsequent Q2 event!
Submitted dossier to the United Kingdom's Regulatory Food Safety Agency
"With nearly all international business paused due to COVID throughout 2020 and Q1 2021, and with slower than expected reopenings, the Company still achieved an incremental QoQ growth of 7.6% . Now, with vaccine rollouts taking place across the country, we are encouraged with reopening rates and excited that our sales, which currently take place in approximately 75% brick-and-mortar businesses, are beginning to reopen," commented Jason Mitchell, N.D., HempFusion's Co-Founder and Chief Executive Officer.
"We remain committed to developing new revenue channels and have entered additional countries including China, Ireland, and the United Kingdom, and we are excited with subsequent quarterly events in which new purchase orders were received, showing early signs of the return of international business. These international POs have the potential to drive millions in revenue. We are working feverishly to accelerate sales through organic channels and the continued pursuit of M&A opportunities; early indications have Q2 shaping up to be our best quarter yet," continued Dr. Mitchell.
Statements of Loss and Comprehensive Loss
The Below is from the Unaudited Condensed Interim Financial Statements for the Three Months Ended March 31, 2021 and 2020; Please Refer to the Complete Report, Including the Notes, Other Statements and Other Contents Therein.
Consolidated net revenue for the three months ended March 31, 2021 increased 7.6% quarter-over-quarter to $983,496 versus $913,646 in Q4-2020, and DTC e-commerce net sales increased 59.3% reflecting increased marketing efforts, a targeted DTC team, and targeted digital promotions. Site traffic increased by 62%, and conversion rates increased to 1.9%. DTC accounted for 24.8% of total revenue in the first quarter of 2021 versus 16.8% for Q4-2020.
International sales increased to $75,994 from nil showing a return to normal from Q4-2020, and early indication of future international orders accelerating and producing incremental quarterly gains. H empFusion maintains a leadership position in retailers across the United States, including the #1 in sales by dollar volume and SKUs in one of the top five largest FDM channel retailers.
Gross profit of $280,205 or 28.5% of net revenue is primarily attributed to improvement in inventory and supply chain management.
Operating expenses were $6,306,703, an increase of 42.9% from $4,414,792 in Q4-2020, primarily attributed to IPO related expenses, including D&O insurance and listing fees, as well as marketing and digital expenses.
Balance Sheet | Cash Position
The Below is from the Unaudited Condensed Interim Financial Statements for the Three Months Ended March 31, 2021 and 2020; Please Refer to the Complete Report, Including the Notes, Other Statements and Other Contents Therein.
The Company ended Q1-2021 with a strong cash position of $17,074,030 ensuring the capital requirements of the Company are met, with ample room for strategic M&A. The Company incurred $2,655,134 in general and administrative expenses and $3,651,569 in sales and marketing expenses.
“In 2019, HempFusion (combined with Probulin on a pro forma basis with respect to 2019) achieved net revenue of $4,627,544, followed by $3,823,638 in 2020. The impact COVID has had on our business is clear. We have adapted. It’s important to note we have strategically bolstered the Company’s online presence with the help of new channels such as Amazon for Probulin and Alibaba’s Tmall for both brands. Our efforts have resulted in early traction and success, as we continue to strengthen our foothold in the direct-to-consumer CBD market. This quarter showed a strong DTC sales increase of 59.3%. We expect this trend to continue as DTC now accounts for 24.8% of total revenue in the first quarter of 2021 versus 16.8% for Q4-2020,” commented Dr. Mitchell.
Conference Call
Management of the Company will host a conference call to discuss the Company's first quarter 2021 results at Monday, May 17, 2021 at 4:15 p.m., Eastern Time. To participate in the call, please dial 888-506-0062. For international callers, dial 973-528-0011. Use Participant Code: 795055. To join the webcast: https://www.webcaster4.com/Webcast/Page/2710/41342 .
A replay will be available from the Investor Relations section of HempFusion’s website at HempFusion.com/corporate-information .
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD Company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com .
Follow HempFusion on Twitter , Facebook and Instagram and Probulin on Twitter , Facebook and Instagram .
FacebookTwitterLinkedInCopy LinkMore
(0) (0)
Hempfusion Wellness Inc (CBDHF) or (CBD-U.TO) + Frankfurt (CBDHF / CBD-U.TO) Stock Research Links
CBDHF / CBD-U.TO Message Board
Followers
|
6
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
179
|
Created
|
01/02/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |